QuickView for zymogen granule membrane (biogroup)

1. L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
3. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
4. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
5. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens

1. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancre…
2. Antibodies to GP2, the major zymogen granule membrane glycoprotein, in inflammatory bowel diseases.
3. Evidence for KCNQ1 K+ channel expression in rat zymogen granule membranes and involvement in cholecy…
4. Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, in patients with gluten-sens…
5. Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's d…

There were no clinical trials for zymogen granule membrane